Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Concentration of ciprofloxacin in human prostatic tissue after oral administration.

Literature DB >> 2944481

Concentration of ciprofloxacin in human prostatic tissue after oral administration.

M Dan, J Golomb, A Gorea, Z Braf, S A Berger.

Abstract

Concomitant concentrations of ciprofloxacin in serum, urine, and prostatic tissue were determined in 15 patients after single oral doses of 750 mg. Levels in tissue ranged from 0.6 to 4.18 micrograms/g, and therapeutic concentrations were demonstrable for up to 9 h after administration. The mean ratio of tissue to serum concentration was 0.93 +/- 0.08 (standard error).

Entities: Chemical Species

Mesh：

Substances：
Quinolines
Ciprofloxacin

Year: 1986 PMID： 2944481 PMCID： PMC176441 DOI： 10.1128/AAC.30.1.88

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

9 in total

1. Pharmacokinetics and tissue penetration of ciprofloxacin.

Authors: B Crump; R Wise; J Dent
Journal: Antimicrob Agents Chemother Date: 1983-11 Impact factor: 5.191

Review 2. Prostatitis, prostatosis, and prostatodynia.

Authors: S M Orland; P M Hanno; A J Wein
Journal: Urology Date: 1985-05 Impact factor: 2.649

3. Intraprostatic concentration of ciprofloxacin and its activity against urinary pathogens.

Authors: J A Hoogkamp-Korstanje; H J van Oort; J J Schipper; T van der Wal
Journal: J Antimicrob Chemother Date: 1984-12 Impact factor: 5.790

4. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.

Authors: N X Chin; H C Neu
Journal: Antimicrob Agents Chemother Date: 1984-03 Impact factor: 5.191

5. The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and Mycoplasmas in vitro.

Authors: G L Ridgway; G Mumtaz; F G Gabriel; J D Oriel
Journal: Eur J Clin Microbiol Date: 1984-08 Impact factor: 3.267

6. Diffusion of ciprofloxacin into prostatic fluid.

Authors: A Dalhoff; W Weidner
Journal: Eur J Clin Microbiol Date: 1984-08 Impact factor: 3.267

7. Comparison of high-pressure liquid chromatography and microbiological assay for the determination of biliary elimination of ciprofloxacin in humans.

Authors: J M Brogard; F Jehl; H Monteil; M Adloff; J F Blickle; P Levy
Journal: Antimicrob Agents Chemother Date: 1985-08 Impact factor: 5.191

8. Ciprofloxacin distribution in prostatic tissue and fluid following oral administration.

Authors: J B Boerema; A Dalhoff; F M Debruyne
Journal: Chemotherapy Date: 1985 Impact factor: 2.544

9. Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urine.

Authors: B Joos; B Ledergerber; M Flepp; J D Bettex; R Lüthy; W Siegenthaler
Journal: Antimicrob Agents Chemother Date: 1985-03 Impact factor: 5.191

9 in total

12 in total

1. Chronic bacterial prostatitis: therapeutic experience with ciprofloxacin.

Authors: W Weidner; H G Schiefer
Journal: Infection Date: 1991 Impact factor: 3.553

2. A new method for assaying antimicrobials in the prostate.

Authors: A C Philpott; E D Crawford; G J Miller
Journal: Infection Date: 1991 Impact factor: 3.553

3. The treatment of chronic bacterial prostatitis.

Authors: A Pfau
Journal: Infection Date: 1991 Impact factor: 3.553

4. Randomized, double-blind comparison of ciprofloxacin and trimethoprim-sulfamethoxazole for complicated urinary tract infections.

Authors: J M Allais; L C Preheim; T A Cuevas; J S Roccaforte; M A Mellencamp; M J Bittner
Journal: Antimicrob Agents Chemother Date: 1988-09 Impact factor: 5.191

Review 5. Antimicrobial Treatment Options for Difficult-to-Treat Resistant Gram-Negative Bacteria Causing Cystitis, Pyelonephritis, and Prostatitis: A Narrative Review.

Authors: Andrew Chou; Elwyn Welch; Andrew Hunter; Barbara W Trautner
Journal: Drugs Date: 2022-03-14 Impact factor: 11.431

6. Inappropriate breast secretions of possible bacterial etiology in the parous nonpuerperal female.

Authors: J J Freeman; R H Altieri; A H Freeman; T Kuo; F Sardinha; C C Buckingham; J J Sklar; K Dyroff; A Floyd
Journal: J Natl Med Assoc Date: 1994-03 Impact factor: 1.798

7. Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005-2013: a population-based analysis.

Authors: K Lahdensuo; A Rannikko; V-J Anttila; A Erickson; A Pätäri-Sampo; M Rautio; H Santti; E Tarkka; M Vaara; K Huotari
Journal: Prostate Cancer Prostatic Dis Date: 2016-08-16 Impact factor: 5.554